Paul Matthew McNeillis

Title: The Innovations of Paul Matthew McNeillis

Introduction

Paul Matthew McNeillis is a notable inventor based in Surrey, GB. He has made significant contributions to the field of biocompatible materials, particularly through his innovative patent. His work focuses on developing advanced polymer compositions that enhance medical applications.

Latest Patents

McNeillis holds a patent for "Biocompatible compositions." This invention involves a polymer formed from monomers, including a zwitterionic monomer, a cationic monomer, and a hydrophobic termonomer. The polymer is designed to be cross-linkable and can be coated onto surfaces from a liquid coating composition. By contacting the coated surface with heparin, the double-coated substrates exhibit improved heparin activity over extended periods compared to commercially available heparinized surfaces. Additionally, the polymers can scavenge heparin from treated blood, which helps avoid the use of potentially toxic heparin inhibitors. The terpolymer is preferably formed from 2-methacryloyloxyethyl-2-(trimethylamonium)phosphate inner salt, choline methacrylate, and n-dodecyl methacrylate.

Career Highlights

McNeillis is associated with Biocompatibles Limited, where he has been instrumental in advancing biocompatible technologies. His work has implications for various medical applications, particularly in improving the performance of heparin-coated surfaces.

Collaborations

Throughout his career, McNeillis has collaborated with notable colleagues, including Manuchehr Porssa and Richard Neil Templar Freeman. These collaborations have contributed to the development of innovative solutions in the field of biocompatible materials.

Conclusion

Paul Matthew McNeillis is a distinguished inventor whose work in biocompatible compositions has the potential to significantly impact medical technology. His innovative approaches to polymer development demonstrate the importance of research and collaboration in advancing healthcare solutions.